High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort
Author(s) -
Caroline Besson,
Rémi Lancar,
Sophie Prévôt,
Pauline Brice,
MarieCaroline Meyohas,
B. Marchou,
Jean Gabarre,
Fabrice Bonnet,
Cécile Goujard,
Olivier Lambotte,
François Boué,
Nicolas Mounier,
Marialuisa Partisani,
F. Raffi,
Régis Costello,
Houria Hendel-Chavez,
Michèle Algarté-Génin,
Selma Trabelsi,
Lucie Marchand,
Martine Raphaël,
Yassine Taoufik,
Dominique Costagliola
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ627
Subject(s) - medicine , cart , abvd , cohort , lymphoma , risk factor , chemotherapy , cyclophosphamide , vincristine , mechanical engineering , engineering
Human immunodeficiency virus (HIV) infection is associated with a high risk of classical Hodgkin's lymphoma (cHL) in the combined antiretroviral therapy (cART) era.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom